{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:07:53Z","timestamp":1778771273221,"version":"3.51.4"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the ongoing global pandemic, has constituted the worst global health disaster in recent years. However, no antiviral drugs have proved clinically efficacious to combat SARS-CoV-2 infection. The SARS-CoV-2 double-membrane vesicle (DMV) pore complex, particularly for its positively charged residues R1613, R1614, R303, R305, and R306, which are highly conserved across \u03b2-coronaviruses and play a critical role in mediating RNA transport and virus replication, has been validated as an effective drug target. Here, we employed computer-aided drug design (CADD) techniques for the first time to screen the antiviral compounds against SARS-CoV-2 by targeting the crystal structure of the SARS-CoV-2 DMV nsp3-4 pore complex. A total of 486,387 drug compounds were subjected to virtual screening, such as toxicity prediction, ADMET prediction, molecular docking, and target analysis. The six compounds (three for each binding site) were selected based on their lowest binding energies. Notably, Compound 391 demonstrated the strongest binding affinity to the critical positively charged residues R1613 and R1614 at binding site 1, meanwhile, Compound 5,157 exhibited the most stable interactions with the essential positively charged residues R303, R305, and R306 at binding site 2. These results demonstrate that Compound 391 and Compound 5,157 exhibit greater potential antiviral effects, which provide a theoretical basis for further confirmation against SARS-CoV-2 <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> studies.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1562187","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:45:03Z","timestamp":1743144303000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Computer-aided drug design for the double-membrane vesicle pore complex inhibitors against SARS-CoV-2"],"prefix":"10.3389","volume":"16","author":[{"given":"Wang","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeeshan","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100450","DOI":"10.1016\/j.chphi.2023.100450","article-title":"A structure-based drug design approach for the identification of antiviral compounds targeting the chikungunya virus RdRp protein.","volume":"8","author":"Ahmed","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1128\/mBio.00524-13","article-title":"Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles.","volume":"4","author":"Angelini","year":"2013","journal-title":"mBio"},{"key":"B3","doi-asserted-by":"publisher","first-page":"123540","DOI":"10.1016\/j.ijbiomac.2023.123540","article-title":"Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays.","volume":"234","author":"Arbaaz","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1021\/acsinfecdis.0c00915","article-title":"Discovery of a potent and selective chikungunya virus envelope protein inhibitor through computer-aided drug design.","volume":"7","author":"Battini","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"105813","DOI":"10.1016\/j.antiviral.2024.105813","article-title":"Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.","volume":"223","author":"Bogacheva","year":"2024","journal-title":"Antiviral Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1126\/science.ade3332","article-title":"Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides.","volume":"379","author":"Bridges","year":"2023","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/nejmc2305030","article-title":"VV116 or nirmatrelvir-ritonavir for oral treatment of Covid-19.","volume":"388","author":"Danyu","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1126\/science.abn1900","article-title":"Stopping pandemics before they start: Lessons learned from SARS-CoV-2.","volume":"375","author":"Edwards","year":"2022","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1056\/nejmoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months.","volume":"385","author":"Einav","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"105760","DOI":"10.1016\/j.micpath.2022.105760","article-title":"Prediction of molecular mimicry between proteins from Trypanosoma sp. and human antigens associated with systemic lupus erythematosus.","volume":"172","author":"Emiliani","year":"2022","journal-title":"Microb. Pathog."},{"key":"B11","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.3390\/molecules27196203","article-title":"Discovery of new VEGFR-2 inhibitors: Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies.","volume":"27","author":"Eslam","year":"2022","journal-title":"Molecules"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.3390\/molecules27227728","article-title":"Covalent warheads targeting cysteine residue: The promising approach in drug development.","volume":"27","author":"Fangjiao","year":"2022","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/1573409919666230612125440","article-title":"Designing a Multi-epitope vaccine against the SARS-CoV-2 variant based on an immunoinformatics approach.","volume":"20","author":"Farhani","year":"2024","journal-title":"Curr. Comput. Aided. Drug Des."},{"key":"B14","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies.","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41596-021-00676-1","article-title":"Accurate determination of protein:ligand standard binding free energies from molecular dynamics simulations.","volume":"17","author":"Fu","year":"2022","journal-title":"Nat. Protoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41467-023-44621-0","article-title":"Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design.","volume":"15","author":"Funk","year":"2024","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities.","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"B18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.compbiolchem.2018.06.005","article-title":"Docking techniques in pharmacology: How much promising?","volume":"76","author":"Gupta","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1295678","DOI":"10.3389\/fmicb.2023.1295678","article-title":"Developing a multi-epitope vaccine candidate to combat porcine epidemic diarrhea virus and porcine deltacoronavirus co-infection by employing an immunoinformatics approach.","volume":"14","author":"Hou","year":"2023","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-024-07817-y","article-title":"Molecular architecture of coronavirus double-membrane vesicle pore complex.","volume":"633","author":"Huang","year":"2024","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00894-022-05288-4","article-title":"Research and study of 2-((4,6 dimethyl pyrimidine-2-yle) thio)-N-phenyl acetamide derivatives as inhibitors of sirtuin 2 protein for the treatment of cancer using QSAR, molecular docking and molecular dynamic simulation.","volume":"28","author":"Ilaghi-Hoseini","year":"2022","journal-title":"J. Mol. Model."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1021\/acs.chemrev.5b00631","article-title":"Emerging computational methods for the rational discovery of allosteric drugs.","volume":"116","author":"Jeffrey","year":"2016","journal-title":"Chem. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape.","volume":"21","author":"John","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7276","DOI":"10.1038\/s41467-021-27511-1","article-title":"Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation.","volume":"12","author":"Keisuke","year":"2021","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations.","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3390\/v14112436","article-title":"Molecular dynamics simulations to decipher the role of phosphorylation of SARS-CoV-2 nonstructural proteins (nsps) in viral replication.","volume":"14","author":"Lamya","year":"2022","journal-title":"Viruses"},{"key":"B27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/14756366.2022.2135511","article-title":"Binding selectivity-dependent molecular mechanism of inhibitors towards CDK2 and CDK6 investigated by multiple short molecular dynamics and free energy landscapes.","volume":"38","author":"Lifei","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1126\/science.aav0569","article-title":"A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels.","volume":"363","author":"Marcus","year":"2019","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejmech.2014.12.030","article-title":"Identification and optimization of Escherichia coli GlmU inhibitors: An in silico approach with validation thereof.","volume":"92","author":"Mehra","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e202112081","DOI":"10.1083\/jcb.202112081","article-title":"VMP1 and TMEM41B are essential for DMV formation during \u03b2-coronavirus infection.","volume":"221","author":"Mingming","year":"2022","journal-title":"J. Cell. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/biology10070594","article-title":"Discovery of novel GMPS inhibitors of candidatus liberibacter asiaticus by structure based design and enzyme kinetic.","volume":"10","author":"Nan","year":"2021","journal-title":"Biology (Basel)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e01658-17","DOI":"10.1128\/mBio.01658-17","article-title":"Expression and cleavage of middle east respiratory syndrome coronavirus nsp3-4 polyprotein induce the formation of double-membrane vesicles that mimic those associated with coronaviral RNA replication.","volume":"8","author":"Oudshoorn","year":"2017","journal-title":"mBio"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13036-023-00342-y","article-title":"Targeting the PEDV 3CL protease for identification of small molecule inhibitors: An insight from virtual screening, ADMET prediction, molecular dynamics, free energy landscape, and binding energy calculations.","volume":"17","author":"Pathak","year":"2023","journal-title":"J. Biol. Eng."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: Shifting paradigms in drug discovery.","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1080\/07391102.2020.1794974","article-title":"Virtual screening, molecular dynamics and structure-activity relationship studies to identify potent approved drugs for Covid-19 treatment.","volume":"39","author":"Rahman","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets.","volume":"6","author":"Robert","year":"2020","journal-title":"Nat. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/cells10040821","article-title":"Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19.","volume":"10","author":"Rohitash","year":"2021","journal-title":"Cells"},{"key":"B38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.sbi.2020.12.016","article-title":"Residue-based pharmacophore approaches to study protein\u2013protein interactions.","volume":"67","author":"Rojan","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"064103","DOI":"10.1063\/1.4774159","article-title":"Amino-acid-dependent main-chain torsion-energy terms for protein systems.","volume":"138","author":"Sakae","year":"2013","journal-title":"J. Chem. Phys."},{"key":"B40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.virol.2017.07.019","article-title":"Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.","volume":"510","author":"Sakai","year":"2017","journal-title":"Virology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12964-023-01104-5","article-title":"Structural and non-structural proteins in SARS-CoV-2: Potential aspects to COVID-19 treatment or prevention of progression of related diseases.","volume":"21","author":"Sareh","year":"2023","journal-title":"Cell. Commun. Signal."},{"key":"B42","doi-asserted-by":"publisher","first-page":"119296","DOI":"10.1016\/j.saa.2020.119296","article-title":"Biophysical insight into the binding mechanism of doxofylline to bovine serum albumin: An in vitro and in silico approach.","volume":"249","author":"Sharmin","year":"2021","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"B43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41586-022-04835-6","article-title":"The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle.","volume":"606","author":"Simona","year":"2022","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/pathogens12091185","article-title":"Non-structural proteins (Nsp): A marker for detection of human coronavirus families.","volume":"12","author":"Tamayo-Ord\u00f3\u00f1ez","year":"2023","journal-title":"Pathogens"},{"key":"B45","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/d41573-022-00177-0","article-title":"Virtual screening yields refined GPCR agonists.","volume":"21","author":"Villanueva","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.tim.2020.05.009","article-title":"Double-membrane vesicles as platforms for viral replication.","volume":"28","author":"Wolff","year":"2020","journal-title":"Trends Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10822-022-00472-3","article-title":"Covalent docking in CDOCKER.","volume":"36","author":"Wu","year":"2022","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"B48","doi-asserted-by":"publisher","first-page":"125596","DOI":"10.1016\/j.foodchem.2019.125596","article-title":"Glycerol induced stability enhancement and conformational changes of \u03b2-lactoglobulin.","volume":"308","author":"Xiaoxia","year":"2020","journal-title":"Food Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1080\/07391102.2020.1796812","article-title":"Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.","volume":"39","author":"Yadav","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B50","doi-asserted-by":"publisher","first-page":"884433","DOI":"10.3389\/fimmu.2022.884433","article-title":"Design of a recombinant multivalent epitope vaccine based on SARS-CoV-2 and its variants in immunoinformatics approaches.","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.3390\/molecules28145315","article-title":"LSD1-based reversible inhibitors virtual screening and binding mechanism computational study.","volume":"28","author":"Zhili","year":"2023","journal-title":"Molecules"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1562187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T06:45:07Z","timestamp":1743144307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1562187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":51,"alternative-id":["10.3389\/fmicb.2025.1562187"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1562187","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"article-number":"1562187"}}